Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Biorxiv : the Preprint Server for Biology|July 16, 2021
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concernJeroen Pollet, Ulrich Strych, Wen-Hsiang Chen, et al.
Vaccine|May 14, 2022
Receptor-binding domain recombinant protein on alum-CpG induces broad protection against SARS-CoV-2 variants of concernJeroen Pollet, Ulrich Strych, Wen-Hsiang Chen, et al.
Biorxiv : the Preprint Server for Biology|November 11, 2020
SARS-CoV-2 RBD219-N1C1: A Yeast-Expressed SARS-CoV-2 Recombinant Receptor-Binding Domain Candidate Vaccine Stimulates Virus Neutralizing Antibodies and T-cell Immunity in MiceJeroen Pollet, Wen-Hsiang Chen, Leroy Versteeg, et al.
Frontiers in Drug Delivery|August 21, 2025
Choice of adjuvant and antigen composition alters the immunogenic profile of a SARS-CoV-2 subunit vaccineWilliam R Lykins, Jeroen Pollet, Jessica A White, et al.
Frontiers in Immunology|December 31, 2024
Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilizationWilliam R Lykins, Jeroen Pollet, Jessica A White, et al.
Vaccines|October 28, 2023
A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2Syamala Rani Thimmiraju, Rakesh Adhikari, Maria Jose Villar, et al.
Expert Review of Vaccines|May 30, 2023
From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global accessPeter J Hotez, Rakesh Adhikari, Wen-Hsiang Chen, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2021
Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunityEtsuro Nanishi, Francesco Borriello, Timothy R O'Meara, et al.
Science Immunology|July 16, 2021
A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primatesMaria Pino, Talha Abid, Susan Pereira Ribeiro, et al.
Science Translational Medicine|November 16, 2021
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged miceEtsuro Nanishi, Francesco Borriello, Timothy R O'Meara, et al.
Pageof 10